10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $744,000 | -50.3% | 9,786 | -2.7% | 0.00% | – |
| Q4 2021 | $1,498,000 | +0.3% | 10,056 | -1.9% | 0.00% | – |
| Q3 2021 | $1,493,000 | -25.6% | 10,255 | 0.0% | 0.00% | – |
| Q2 2021 | $2,008,000 | +7.2% | 10,255 | -0.9% | 0.00% | – |
| Q1 2021 | $1,874,000 | +30.0% | 10,352 | +1.7% | 0.00% | – |
| Q4 2020 | $1,442,000 | +13.3% | 10,181 | -0.2% | 0.00% | – |
| Q3 2020 | $1,273,000 | +53.0% | 10,203 | +9.5% | 0.00% | – |
| Q2 2020 | $832,000 | +46.0% | 9,316 | +1.9% | 0.00% | – |
| Q1 2020 | $570,000 | -18.5% | 9,146 | -0.3% | 0.00% | – |
| Q4 2019 | $699,000 | -81.7% | 9,169 | -87.9% | 0.00% | -100.0% |
| Q3 2019 | $3,812,000 | – | 75,627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
| Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
| Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
| Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
| Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
| Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
| RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
| Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
| Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |